Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study.
In this randomized crossover trial we investigated whether the use of controlled ovarian hyperstimulation with low-dose human menopausal gonadotrophin in couples with male subfertility leads to a higher probability of conception when intrauterine insemination (IUI) is applied. We also investigated whether the efficacy of IUI in natural or stimulated cycles was related to the severity of male subfertility. Seventy-four couples completed 308 treatment cycles. Thirteen pregnancies occurred after IUI in a natural cycle (pregnancy rate per completed cycle: 8.4%) and 21 after IUI in a stimulated cycle (pregnancy rate per completed cycle: 13.7%). The difference between the two treatment modalities was not statistically significant. The efficacy of IUI in stimulated cycles was related to the severity of the semen defect. In couples with a total motile sperm count < 10 x 10(6), ovarian stimulation did not improve treatment outcome, while it did in couples with a total motile sperm count > or = 10 x 10(6). Compared with the expected chance of conceiving spontaneously without treatment, both natural and stimulated cycles improved the probability of conception. We conclude that, for the group as a whole, ovarian stimulation did not improve the probability of conception. However, in couples with less severe semen defects, ovarian stimulation did improve the probability of conception.
Cohlen
B J
BJ
University Hospital Utrecht, Department of Reproductive Medicine, The Netherlands.
te Velde
E R
ER
van Kooij
R J
RJ
Looman
C W
CW
Habbema
J D
JD
D000328:Adult; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage*; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007248:Infertility, Male; D008297:Male; D008596:Menotropins / Q000008:administration & dosage*; D008875:Middle Aged; D010062:Ovulation Induction; D011247:Pregnancy; D018873:Pregnancy Rate; D013075:Sperm Capacitation
D005300:Fertility Agents, Female; D008596:Menotropins